Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 27 1
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Baricitinib Emergency use authorization Used to treat other disease Other treatment Feb/03/2022 33 2
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Jan/04/2022 16 1
Gam-COVID-Vac Emergency use authorization Experimental Vaccine Dec/23/2021 3 1
Emtricitabine Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 2 2
Tenofovir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 4 3
Excel (.xslx) CSV (.csv)